Journey Medical Corporation (DERM) Dividend History

Company News

• Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

  Journey Medical Corporation announced that the FDA has approved Emrosi™, a new treatment for inflammatory lesions of rosacea in adults. The approval is supported by positive data from the company's Phase 3 clinical trials.

  GlobeNewswire Inc.
• Neurocrine Biosciences (NBIX) Q1 Earnings Miss Estimates

  Neurocrine (NBIX) delivered earnings and revenue surprises of -59.62% and 0.60%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  Zacks Investment Research

  Featured Companies: NBIX
• Journey Medical And 2 Other Stocks Under $4 Insiders Are Buying

  The Dow Jones index closed higher by over 475 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Retractable Technologies The Trade: Retractable Technologies, Inc. (NYSE: RVP) President and CEO Thomas J Shaw acquired a total of 5,096 shares an average price of $1.18. To ...

  Benzinga

  Featured Companies: CIA RVP